Abiopharma

🔍 Simhambhatla Ravi (Executive)

Company: AVIS BUDGET GROUP, INC. (CAR)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Sold 2,936 shares of Common Stock at $138.27 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,576.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,490 shares of Common Stock at $139.53 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,086.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 276 shares of Common Stock at $140.27 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,810.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Price reflects the weighted average sale price for the sale transactions made on the date reported above. Sale prices ranged from $138 to $138.79. The reporting person will provide, upon request by the Staff, the Company, or a security holder of the Company, full information regarding the number of shares purchased or sold at each separate price.
• F2: Price reflects the weighted average sale price for the sale transactions made on the date reported above. Sale prices ranged from $139.22 to $140. The reporting person will provide, upon request by the Staff, the Company, or a security holder of the Company, full information regarding the number of shares purchased or sold at each separate price.
• F3: Price reflects the weighted average sale price for the sale transactions made on the date reported above. Sale prices ranged from $140.25 to $140. 35. The reporting person will provide, upon request by the Staff, the Company, or a security holder of the Company, full information regarding the number of shares purchased or sold at each separate price.
• REMARKS: EVP, Chief Digital & Innovation Officer